Market Research Logo

US Market Report for Neuromodulation Devices 2017 - MedCore

US Market Report for Neuromodulation Devices 2017 - MedCore

Market growth will be propelled by wider acceptance of neuromodulation products, allowing them to be used on a larger proportion of potential patients. In addition, many neuromodulation patients require multiple devices over their lifetimes because the battery life of neuromodulation devices are limited, ranging from three to ten years. Furthermore, the neuromodulation market had a relatively low penetration rate in 2016 and therefore has excellent growth potential. The GES market will be the slowest growing segment in the neuromodulation device market because the procedure has not gained widespread acceptance and the device only has humanitarian device exemption (HDE) status, limiting its usage to 4,000 units per year. The fastest growing segment is projected to be the DBS market. This market will benefit from the expected entry of new competitors into the market, which will lead to increasing ASP and unit sales through the established sales network of St. Jude Medical and potentially Boston Scientific.

Neuromodulation devices are used for regulating the nervous system, either to correct an abnormality in the system or to treat a condition. The devices consist of a pulse generator, leads and electrodes. The electrodes are connected to the desired stimulation area on one end and the pace generator on the other using leads. The pulse generator delivers small pulses of electricity from an internal battery to regulate the activity of the indicated nerve. This report covers the markets for spinal cord stimulators (SCSs), vagus nerve stimulators (VNSs), deep brain stimulators (DBSs), gastric electric stimulators (GESs) and sacral nerve stimulators (SNSs).


EXECUTIVE SUMMARY
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic brain injury
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Neuromodulation Devices
3.1.1.1 Introduction
3.1.1.2 Spinal Cord Stimulators
3.1.1.3 Vagus Nerve Stimulators
3.1.1.4 Deep Brain Stimulators
3.1.1.5 Gastric Electric Stimulators
3.1.1.6 Sacral Nerve Stimulators
3.1.1.7 Product Matrix for Neuromodulation Device Market: Core Companies
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Neuromodulation Devices
3.3 CLINICAL TRIALS
3.3.1 Neuromodulation Devices
NEUROMODULATION DEVICE MARKET
4.1 INTRODUCTION
4.1.1 Spinal Cord Stimulators
4.1.2 Vagus Nerve Stimulators
4.1.3 Deep Brain Stimulators
4.1.4 Gastric Electric Stimulators
4.1.5 Sacral Nerve Stimulators
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Neuromodulation Device Market
4.3.2 Spinal Cord Stimulator Market
4.3.2.1 Spinal Cord Stimulator Implants by Application
4.3.3 Vagus Nerve Stimulator Market
4.3.4 Deep Brain Stimulator Market
4.3.5 Gastric Electric Stimulator Market
4.3.6 Sacral Nerve Stimulator Market
4.4 DRIVERS AND LIMITERS
4.4.1 Spinal Cord Stimulator Market
4.4.1.1 Market Drivers
4.4.1.2 Market Limiters
4.4.2 Vagus Nerve Stimulator Market
4.4.2.1 Market Drivers
4.4.2.2 Market Limiters
4.4.3 Deep Brain Stimulator Market
4.4.3.1 Market Drivers
4.4.3.2 Market Limiters
4.4.4 Gastric Electric Stimulator Market
4.4.4.1 Market Drivers
4.4.4.2 Market Limiters
4.4.5 Sacral Nerve Stimulator Market
4.4.5.1 Market Drivers
4.4.5.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023
Chart 4 1: Neuromodulation Device Market by Segment, U.S., 2013 – 2023
Chart 4 2: Neuromodulation Device Market Breakdown, U.S., 2016
Chart 4 3: Neuromodulation Device Market Breakdown, U.S., 2023
Chart 4 4: Total Neuromodulation Device Market, U.S., 2013 – 2023
Chart 4 5: Spinal Cord Stimulator Market, U.S., 2013 – 2023
Chart 4 6: Vagus Nerve Stimulator Market, U.S., 2013 – 2023
Chart 4 7: Deep Brain Stimulator Market, U.S., 2013 – 2023
Chart 4 8: Gastric Electric Stimulator Market, U.S., 2013 – 2023
Chart 4 9: Sacral Nerve Stimulator Market, U.S., 2013 – 2023
Chart 4 10: Leading Competitors, Neuromodulation Device Market, U.S., 2016
List of Figures
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2016
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016
Figure 1 9: Neurological Device Markets Covered, U.S., 2016
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2)
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2)
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 14: Key Report Updates
Figure 1 15: Version History
Figure 2 1: Neurology Disease Overview
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Class 2 Device Recall: RestoreSensor and RestoreSensor SureScan, Medtronic Neuromodulation
Figure 3 2: Class 2 Device Recall: DBS Pocket Adaptor, Medtronic Neuromodulation
Figure 3 3: Class 2 Device Recall: Specify neurostimulation leads, Medtronic Neuromodulation
Figure 3 4: Class 2 Device Recall: Itrel 3 IPG; InterStim II INS: InterStim INS ; Enterra INS
Figure 3 5: Class 2 Device Recall: Percutaneous Trial Lead Kits, St. Jude Medical, Inc.
Figure 3 6: Class 2 Device Recall: Brio DBS System, Advanced Neuromodulation Systems Inc.
Figure 3 7: Class 2 Device Recall: RestoreUltra and RestoreSensor, Medtronic Neuromodulation
Figure 3 8: Neuromodulation device: The Motor Network in Essential Tremor: Mechanisms of Therapy
Figure 3 9: Neuromodulation device: Treatment of Bipolar Depression With H1-Coil Deep Brain rTMS
Figure 3 10: Neuromodulation device: A Pilot Study of Deep Brain Stimulation of the Amygdala
Figure 3 11: Neuromodulation device: MAPS Trial: Matrix And Platinum Science (MAPS)
Figure 4 1: Neuromodulation Device by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 2: Total Neuromodulation Device Market, U.S., 2013 – 2023
Figure 4 3: Spinal Cord Stimulator Market, U.S., 2013 – 2023
Figure 4 4: Spinal Cord Stimulator Implants by Application, U.S., 2016
Figure 4 5: Vagus Nerve Stimulator Market, U.S., 2013 – 2023
Figure 4 6: Deep Brain Stimulator Market, U.S., 2013 – 2023
Figure 4 7: Gastric Electric Stimulator Market, U.S., 2013 – 2023
Figure 4 8: Sacral Nerve Stimulator Market, U.S., 2013 – 2023
Figure 4 9: Drivers and Limiters, Spinal Cord Stimulator Market, U.S., 2016
Figure 4 10: Drivers and Limiters, Vagus Nerve Stimulator Market, U.S., 2016
Figure 4 11: Drivers and Limiters, Deep Brain Stimulator Market, U.S., 2016
Figure 4 12: Drivers and Limiters, Gastric Electric Stimulator Market, U.S., 2016
Figure 4 13: Drivers and Limiters, Sacral Nerve Stimulator Market, U.S., 2016
Figure 4 14: Leading Competitors, Neuromodulation Device Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report